Rachel Evans

675 total citations
29 papers, 434 citations indexed

About

Rachel Evans is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Genetics. According to data from OpenAlex, Rachel Evans has authored 29 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Surgery and 7 papers in Genetics. Recurrent topics in Rachel Evans's work include Neurogenetic and Muscular Disorders Research (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Rachel Evans is often cited by papers focused on Neurogenetic and Muscular Disorders Research (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Rachel Evans collaborates with scholars based in United Kingdom, United States and Australia. Rachel Evans's co-authors include Keith Cartwright, Rhonwen Morris, Petra Derrington, David A. B. Dance, Michael D. Smith, Neil Hawkins, David A. Scott, Leslie Cunningham, Anadi Mahajan and Keith R. Abrams and has published in prestigious journals such as Blood, Journal of Clinical Microbiology and British journal of surgery.

In The Last Decade

Rachel Evans

28 papers receiving 389 citations

Peers

Rachel Evans

EPIDE

SURGE

GENET

PRM

Atif Awan Ireland

Heiko Billing Germany

Noha Irani‐Hakime Lebanon

H Karle Denmark

Fatma Hüsniye Dılek Türkiye

Ahmed Sellami Tunisia

Gabriel Veniamin Cozma Romania

R.J.M. ten Berge Netherlands

Rachel Thompson United Kingdom

D.M. Paternoster Italy

Atif Awan Ireland

Rachel Evans

117 ×0.6

EPIDE

84 ×0.8

SURGE

87 ×1.4

56 ×0.9

GENET

111 ×1.9

PRM

Citations per year, relative to Rachel Evans Rachel Evans (= 1×) peers Atif Awan

Countries citing papers authored by Rachel Evans

Since Specialization

Citations

This map shows the geographic impact of Rachel Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Evans more than expected).

Fields of papers citing papers by Rachel Evans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Evans. The network helps show where Rachel Evans may publish in the future.

Co-authorship network of co-authors of Rachel Evans

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Evans. A scholar is included among the top collaborators of Rachel Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Evans. Rachel Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stubbs, Matthew, Prabhu Gounder, Matthew Carter, et al.. (2025). Long-term follow-up outcomes in congenital thrombotic thrombocytopenic purpura. Blood. 146(20). 2457–2463.

Evans, Rachel, Neil Hawkins, Anadi Mahajan, et al.. (2024). Long-Term Comparative Efficacy and Safety of Risdiplam and Nusinersen in Children with Type 1 Spinal Muscular Atrophy. Advances in Therapy. 41(6). 2414–2434. 9 indexed citations

Sajeev, Gautam, Rachel Evans, Neil Hawkins, et al.. (2023). P08 Long-term comparative efficacy and safety of risdiplam versus nusinersen in children with Type 1 spinal muscular atrophy (SMA). Neuromuscular Disorders. 33. S164–S164. 2 indexed citations

Hawkins, Neil, et al.. (2023). Overall survival in the UK in mycosis fungoides or Sézary syndrome cutaneous T-cell lymphoma: comparative effectiveness of mogamulizumab versus current standard of care. Journal of Comparative Effectiveness Research. 12(10). e230017–e230017. 2 indexed citations

Crawford, Thomas O., et al.. (2023). P224 Effect of apitegromab on motor function at 36 months in patients with nonambulatory spinal muscular atrophy aged 2-12 years old. Neuromuscular Disorders. 33. S91–S91. 1 indexed citations

Seefried, Lothar, Martin Biosse Duplan, Karine Briot, et al.. (2023). Anticipated effects of burosumab treatment on long-term clinical sequelae in XLH: expert perspectives. Frontiers in Endocrinology. 14. 1211426–1211426. 10 indexed citations

Daigl, Monica, Ksenija Gorni, Rachel Evans, et al.. (2022). How does risdiplam compare with other treatments for Types 1–3 spinal muscular atrophy: a systematic literature review and indirect treatment comparison. Journal of Comparative Effectiveness Research. 11(5). 347–370. 23 indexed citations

Evans, Rachel, Neil Hawkins, Dominic Muston, et al.. (2021). Exploring the Impact of Treatment Switching on Overall Survival from the PROfound Study in Homologous Recombination Repair (HRR)-Mutated Metastatic Castration-Resistant Prostate Cancer (mCRPC). Targeted Oncology. 16(5). 613–623. 5 indexed citations

Sánchez, Juan José García, Juliette C. Thompson, David A. Scott, et al.. (2021). Treatments for Chronic Kidney Disease: A Systematic Literature Review of Randomized Controlled Trials. Advances in Therapy. 39(1). 193–220. 22 indexed citations

10.

Muszbek, N., et al.. (2021). Changes in treatment pattern and costs in advanced hepatocellular carcinoma (HCC). Expert Review of Pharmacoeconomics & Outcomes Research. 22(1). 147–154. 2 indexed citations

11.

Muszbek, N., et al.. (2020). Cost–Utility Analysis of Selective Internal Radiation Therapy with Y-90 Resin Microspheres in Hepatocellular Carcinoma. Future Oncology. 17(9). 1055–1068. 9 indexed citations

12.

Evans, Rachel, et al.. (2019). PCN21 TREATMENT COMPARISONS IN PATIENTS WITH UNRESECTABLE HEPTOCELLULAR CARCINOMA (HCC) WHO ARE INELIGIBLE FOR TRANSARTERIAL CHEMOEMBOLISATION (TACE). Value in Health. 22. S438–S439. 1 indexed citations

13.

Muszbek, N., et al.. (2019). PCN78 CHANGES IN HEALTH STATE COSTS IN HEPATOCELLULAR CARCINOMA (HCC). Value in Health. 22. S451–S451. 1 indexed citations

14.

Muszbek, N., et al.. (2019). PCN83 COST-UTILITY ANALYIS OF SELECTIVE INTERNAL RADIATION THERAPY (SIRT) WITH Y-90 RESIN MICROSPHERES IN HEPATOCELLULAR CARCINOMA (HCC). Value in Health. 22. S452–S452. 2 indexed citations

15.

Daigl, Monica, Anna Kotzeva, Ksenija Gorni, et al.. (2019). PRO12 HOW DOES RISDIPLAM COMPARE IN INFANTILE ONSET SPINAL MUSCOLAR ATROPHY (SMA)? PRELIMINARY INDIRECT TREATMENT COMPARISONS BASED ON FIREFISH PART 1 DATA. Value in Health. 22. S843–S843. 5 indexed citations

16.

Muszbek, N., et al.. (2019). PCN98 COST-COMPARISON ANALYSIS OF SELECTIVE INTERNAL RADIATION THERAPY (SIRT) AND TRANSARTERIAL CHEMOEMBOLISATION (TACE) IN UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC). Value in Health. 22. S455–S455. 1 indexed citations

17.

Winfree, Katherine B., Mark E. Boye, Mickaël Basson, et al.. (2017). A cost-effectiveness analysis of first-line induction and maintenance treatment sequences in patients with advanced nonsquamous non-small-cell lung cancer in France. ClinicoEconomics and Outcomes Research. Volume 9. 505–518. 5 indexed citations

18.

Evans, Rachel, et al.. (2010). Perinatal evolution of mesenchymal hamartoma of the chest wall. Journal of Pediatric Surgery. 45(12). e37–e40. 16 indexed citations

19.

Smith, Michael D., Petra Derrington, Rachel Evans, et al.. (2003). Rapid Diagnosis of Bacteremic Pneumococcal Infections in Adults by Using the Binax NOW Streptococcus pneumoniae Urinary Antigen Test: a Prospective, Controlled Clinical Evaluation. Journal of Clinical Microbiology. 41(7). 2810–2813. 150 indexed citations

20.

Evans, Rachel, et al.. (1960). A CONGENITAL MALIGNANT SYNOVIAL TUMOUR OF BONE. Journal of Bone and Joint Surgery - British Volume. 42-B(4). 742–748. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact